Please assess the completion status of the following clinical trial:

Trial Title: Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Males or females at least 18 years of age, of any ethnic origin~* Type 1 or 2 diabetes mellitus~* Pain score greater than or equal to 4 on the 11-point numeric pain rating scale~Exclusion Criteria:~* Neurologic disorders unrelated to diabetic neuropathy that may confuse or confound the assessment of neuropathic pain.~* Presence of severe pain associated with conditions other than diabetic peripheral neuropathy, that could confound the assessment or self-evaluation of pain due to DPN.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).